DPY19L3 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 3.607800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.164000E-01
Normal-vs-Stage2
3.407800E-01
Normal-vs-Stage3
5.388500E-02
Normal-vs-Stage4
8.432000E-01
Stage1-vs-Stage2
4.357800E-01
Stage1-vs-Stage3
7.230200E-02
Stage1-vs-Stage4
8.881000E-01
Stage2-vs-Stage3
1.524620E-01
Stage2-vs-Stage4
4.183400E-01
Stage3-vs-Stage4
9.115900E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
3.379600E-01
Normal-vs-AfricanAmerican
9.617600E-01
Normal-vs-Asian
1.371380E-01
Caucasian-vs-AfricanAmerican
2.108200E-01
Caucasian-vs-Asian
2.283200E-01
AfricanAmerican-vs-Asian
8.868100E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
3.353800E-01
Normal-vs-Female
4.144400E-01
Male-vs-Female
6.901600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.317800E-01
Normal-vs-Age(41-60Yrs)
6.665200E-01
Normal-vs-Age(61-80Yrs)
2.761200E-01
Normal-vs-Age(81-100Yrs)
7.308400E-02
Age(21-40Yrs)-vs-Age(41-60Yrs)
8.670400E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
3.441900E-02
Age(21-40Yrs)-vs-Age(81-100Yrs)
1.649960E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
5.203800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.720100E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
1.261760E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
1.367420E-01
Normal-vs-Daily Drinker
5.287900E-02
Normal-vs-Weekly Drinker
5.123800E-01
Normal-vs-Occasional Drinker
3.519600E-01
Normal-vs-Social Drinker
9.436400E-01
Non Drinker-vs-Daily Drinker
3.214000E-01
Non Drinker-vs-Weekly Drinker
1.328770E-01
Non Drinker-vs-Occasional Drinker
3.519600E-01
Non Drinker-vs-Social Drinker
1.041440E-01
Daily Drinker-vs-Weekly Drinker
2.588300E-02
Daily Drinker-vs-Occasional Drinker
8.553800E-02
Daily Drinker-vs-Social Drinker
3.709900E-02
Weekly Drinker-vs-Occasional Drinker
5.795400E-01
Weekly Drinker-vs-Social Drinker
5.213000E-01
Occasional Drinker-vs-Social Drinker
2.772200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
5.144600E-01
Normal-vs-Grade 2
3.486400E-01
Normal-vs-Grade 3
3.740800E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
8.128800E-01
Grade 1-vs-Grade 3
9.768000E-01
Grade 1-vs-Grade 4
5.144600E-01
Grade 2-vs-Grade 3
7.404200E-01
Grade 2-vs-Grade 4
3.486400E-01
Grade 3-vs-Grade 4
3.740800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
1.972840E-01
Normal-vs-NonDiabetic
2.969800E-01
Diabetic-vs-NonDiabetic
5.704200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
9.794300E-02
Normal-vs-NoPancreatitis
3.190800E-01
Pancreatitis-vs-NoPancreatitis
3.637200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.473800E-01
Normal-vs-N1
3.409800E-01
N0-vs-N1
9.535600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
4.447600E-01
Normal-vs-TP53-NonMutant
7.419600E-01
TP53-Mutant-vs-TP53-NonMutant
2.500200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
